🦊/Companies

Prenosis

Founded 2014 · 44 employees on LinkedIn · 6 known investors

Find your way into Prenosis

Prenosis develops AI-powered precision medicine diagnostics for acute care, built on its Immunix platform and a biobank of clinical data for infection. Its Sepsis ImmunoScore is an FDA-authorized AI diagnostic that integrates biomarkers and clinical data into hospital electronic medical records to diagnose sepsis and predict patient outcomes.

Investors · 6

Also in the syndicate · 5

Carle HealthIllinois Department of Commerce and Economic Opportunity (DCEO)Labcorp Venture FundUC InvestmentsUCI Health Ventures

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Non-dilutive funding · 6 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2023$1.3M
National Institutes of Health (NIH)National Institutes of HealthPhase II2023$1.2M
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$2M
National Science FoundationPhase II2018$704.5K
National Science FoundationPhase I2017$150K
Centers for Disease Control and Prevention (CDC)Centers for Disease Control and PreventionPhase I2017$150K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

What does Prenosis do?
Prenosis develops AI-powered precision medicine diagnostics for acute care, built on its Immunix platform and a biobank of clinical data for infection. Its Sepsis ImmunoScore is an FDA-authorized AI diagnostic that integrates biomarkers and clinical data into hospital electronic medical records to diagnose sepsis and predict patient outcomes.
Who are Prenosis's investors?
Prenosis's investors include PACE Healthcare Capital.